I-Ticagrelor

-Delile

• Ngaphambi kokuthatha i-ticagrelor,
• I-Ticagrelor ingadala imiphumela emibi. Tshela udokotela wakho uma kukhona kulezi zimpawu ezinzima noma ezingapheli:
• Eminye imiphumela emibi ingaba mibi. Uma uhlangabezana nenye yalezi zimpawu noma lezo ezibalwe esigabeni ESIBALULEKILE SESEXWAYISO, shayela udokotela wakho ngokushesha:
• Izimpawu zokudlula ngokweqile zingafaka okulandelayo:

I-ticagrelor ingadala ukopha okungathi sína noma okusongela ukuphila. Tshela udokotela wakho uma ngabe njengamanje uke waba noma unesimo esidala ukuthi uphume igazi kalula kunokujwayelekile; uma usanda kuhlinzwa noma walimala nganoma iyiphi indlela; noma uma uke waba nesilonda esiswini noma wake waba naso; ukopha esiswini sakho, emathunjini, noma ebuchosheni; i-stroke noma i-mini-stroke; isimo esingadala ukopha emathunjini akho njengama-polyps (ukukhula okungavamile emgqeni wamathumbu amakhulu); noma isifo sesibindi. Tshela udokotela kanye nosokhemisi wakho uma uthatha imishanguzo engadala ukopha kubandakanya ama-anticoagulants (ama-thinner egazi) njenge-warfarin (i-Coumadin, i-Jantoven); i-heparin; eminye imithi yokwelapha noma yokuvimbela amahlule egazi; noma ukusetshenziswa okuvamile kwemithi engeyona i-steroidal anti-inflammatory efana ne-ibuprofen (Advil, Motrin) ne-naproxen (Aleve). Udokotela wakho futhi mhlawumbe ngeke anikeze i-ticagrelor uma kungenzeka ukuthi udinga ukuhlinzwa kwenhliziyo (uhlobo oluthile lokuhlinzwa kwenhliziyo evulekile) ngaso leso sikhathi. Ngenkathi uthatha i-ticagrelor, mhlawumbe uzolimaza bese wopha kalula kunokwejwayelekile noma wophe isikhathi eside kunokujwayelekile futhi kungenzeka ube namakhala okopha. Kodwa-ke, uma uhlangabezana nalezi zimpawu ezilandelayo, shayela udokotela wakho ngokushesha: ukopha okungachazeki, okunzima, okuhlala isikhathi eside, noma okungalawuleki; umchamo obomvana noma onsundu; okubomvu noma okumnyama, izitulo zokulinda; hlanza okunegazi noma okubukeka njengezizathu zekhofi; noma ukukhwehlela igazi noma amahlule egazi.

Uma uhlinzwa, kufaka phakathi ukuhlinzwa kwamazinyo, noma yiluphi uhlobo lwenqubo yezokwelapha, tshela udokotela noma udokotela wamazinyo ukuthi uthatha i-ticagrelor. Udokotela wakho uzokutshela ukuthi uyeke ukuthatha i-ticagrelor okungenani izinsuku ezingama-5 ngaphambi kokuhlinzwa kwakho.

Udokotela wakho mhlawumbe uzokutshela ukuthi uthathe umthamo omncane we-aspirin (ngaphansi kuka-100 mg) ngesikhathi sokwelashwa kwakho, kepha ukuthatha imithamo ephezulu ye-aspirin kungavimbela i-ticagrelor ekusebenzeni ngendlela efanele. Imithi eminingi ye-over-the-counter (OTC) iqukethe i-aspirin, ngakho-ke qiniseka ukuthi ufunda wonke amalebula ngokucophelela. Ungathathi i-aspirin eyengeziwe noma imikhiqizo equkethe ama-aspirin ngesikhathi sokwelashwa kwakho nge-ticagrelor ngaphandle kokukhuluma nodokotela wakho.

Udokotela wakho noma usokhemisi uzokunikeza ishidi lemininingwane yesiguli lomkhiqizi (Umhlahlandlela Wezokwelapha) lapho uqala ukwelashwa nge-ticagrelor futhi isikhathi ngasinye ugcwalisa umuthi wakho. Funda imininingwane ngokucophelela bese ubuza udokotela noma usokhemisi wakho uma unemibuzo. Ungavakashela futhi iwebhusayithi ye-Food and Drug Administration (FDA) (http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm) noma iwebhusayithi yomkhiqizi ukuthola i-Medication Guide.

Khuluma nodokotela wakho ngezingozi zokuthatha i-ticagrelor.

I-Ticagrelor isetshenziselwa ukuvimbela isifo esibi noma esisongela impilo senhliziyo noma isifo sohlangothi, noma ukufa kwabantu abaye bahlaselwa yinhliziyo noma abane-acute coronary syndrome (i-ACS; ukuvinjelwa kokugeleza kwegazi kuye enhliziyweni). Ibuye isetshenziselwe ukuvimbela amahlule egazi ukuthi angakheki kubantu abathole ama-coronary stents (amashubhu ensimbi ahlinzwe abekwe emithanjeni yegazi evalekile ukwenza ukugeleza kwegazi) ukwelapha i-ACS. I-Ticagrelor isetshenziselwa ukunciphisa ubungozi bokuhlaselwa yinhliziyo okokuqala noma isifo sohlangothi kubantu abasengozini yesifo se-coronary artery (CAD; kunciphise ukugeleza kwegazi kuye enhliziyweni). Ibuye isetshenziselwe ukunciphisa ubungozi bokunye ukuphazamiseka okungathi sína kakhulu kubantu abanesifo sohlangothi esincane noma esilinganiselwe noma i-ischemic attack yesikhashana (i-TIA; i-ministroke). I-Ticagrelor isekilasini lemithi ebizwa ngemithi yama-antiplatelet. Isebenza ngokuvimbela ama-platelet (uhlobo lweseli legazi) ekuqoqeni nasekwenzeni amahlule angadala isifo senhliziyo noma isifo sohlangothi.

I-Ticagrelor iza njengethebhulethi ezothathwa ngomlomo. Imvamisa kuthathwa ngokudla noma ngaphandle kokudla kabili ngosuku. Thatha i-ticagrelor ngasikhathi sinye nsuku zonke. Landela izinkomba ezikulebuli kadokotela wakho ngokucophelela, bese ubuza udokotela noma usokhemisi wakho ukuthi akuchaze nganoma iyiphi ingxenye ongayiqondi. Thatha i-ticagrelor njengoba nje iqondisiwe. Ungayithathi kancane noma uyithathe kaningi kunokuyalelwa ngudokotela wakho.

Uma ungakwazi ukugwinya amaphilisi e-ticagrelor, ungahle uyichoboze futhi uyixube namanzi. Phuza leyo ngxube ngokushesha, bese ugcwalisa ingilazi ngamanzi bese uyayaluza uphinde uyiphuze leyo ngxube ngokushesha.Uma uneshubhu le-nasogastric (NG), udokotela wakho noma usokhemisi uzokuchaza ukuthi ungayilungiselela kanjani i-ticagrelor ukunikela nge-NG tube.

I-Ticagrelor izosiza ukuvimbela izinkinga ezinkulu ngenhliziyo yakho nemithambo yegazi kuphela uma uthatha umuthi. Qhubeka nokuthatha i-ticagrelor noma ngabe uzizwa uphilile. Ungayeki ukuthatha i-ticagrelor ngaphandle kokukhuluma nodokotela wakho. Uma uyeka ukuthatha i-ticagrelor, kunengozi enkulu yokuthi ungahlaselwa yisifo senhliziyo noma isifo sohlangothi. Uma une-stent, kunengozi enkulu yokuthi ungakha i-clot yegazi ku-stent uma uyeka ukuthatha i-ticagrelor ngokushesha okukhulu.

Lo muthi ungabekelwa okunye ukusetshenziswa; buza udokotela wakho noma usokhemisi ukuthola eminye imininingwane.

Ngaphambi kokuthatha i-ticagrelor,

• Tshela udokotela wakho kanye nosokhemisi uma unegciwane ku-ticagrelor, noma imuphi omunye umuthi, noma iziphi izithako ezibhebheni ze-ticagrelor. Buza usokhemisi wakho noma uhlole Umhlahlandlela Wezokwelapha ukuthola uhlu lwezithako.
• Tshela udokotela wakho kanye nosokhemisi ukuthi imiphi eminye imishanguzo kadokotela neyokungabhalisi, amavithamini, izithasiselo zokudla okunempilo, nemikhiqizo yamakhambi oyithathayo noma ohlela ukuyithatha. Qiniseka ukuthi uyayisho imishanguzo ebhalwe esigabeni ESIBALULEKILE SESEXWAYISO nanoma yikuphi okulandelayo: ama-antibiotics afana ne-clarithromycin (i-Biaxin, e-PrevPak) ne-telithromycin (Ketek); imishanguzo yokulwa ne-fungal efana ne-itraconazole (i-Onmel, i-Sporanox), i-ketoconazole (i-Nizoral), ne-voriconazole (i-Vfend); imithi yokwehlisa i-cholesterol efana ne-lovastatin (i-Altoprev, ku-Advicor) ne-simvastatin (iZocor, eSimcor, eVytorin); i-digoxin (i-Lanoxin); imithi yomfutho wegazi ophakeme; imishanguzo yegciwane lesandulela ngculazi (i-HIV) efana ne-atazanavir (Reyataz, e-Evotaz), indinavir (Crixivan), i-nelfinavir (i-Viracept), i-ritonavir (i-Norvir, e-Kaletra, e-Viekira Pak), ne-saquinavir (i-Invirase); imithi yokuquleka efana ne-carbamazepine (Carbatrol, Equetro, Tegretol, abanye), phenobarbital, ne-phenytoin (Dilantin); nefazodone; imishanguzo ye-opioid (narcotic) yezinhlungu ezifana ne-hydrocodone (e-Hydrocet, eVicodin, abanye), i-morphine (i-Avinza, iKadian, i-MSIR, abanye), noma i-oxycodone (i-OxyContin, ePercocet, eRoxicet, abanye); kanye ne-rifampin (Rifadin, Rimactane, eRifamate, eRifater). Udokotela wakho angadinga ukushintsha imithamo yemithi yakho noma akuqaphele ngokucophelela ngemiphumela emibi.
• Tshela udokotela wakho uma uke waba nokushaya kwenhliziyo okungajwayelekile okungalungiswa yi-pacemaker, uhlobo lwesifo samaphaphu njengesifo esingelapheki se-pulmonary disease (i-COPD; iqembu lezifo ezithinta amaphaphu nemigwaqo yomoya) noma i-asthma.
• utshele udokotela wakho uma ukhulelwe, hlela ukukhulelwa, noma uncelisa. Uma ukhulelwa ngenkathi uthatha i-ticagrelor, shayela udokotela wakho.

Ngaphandle kokuthi udokotela wakho akutshele ngenye indlela, qhubeka nokudla okuvamile.

Yeqa umthamo ophuthelwe bese uqhubeka nesimiso sakho sokulinganisa esivamile. Ungathathi umthamo ophindwe kabili ukwenza okulahlekile.

I-Ticagrelor ingadala imiphumela emibi. Tshela udokotela wakho uma kukhona kulezi zimpawu ezinzima noma ezingapheli:

• isiyezi
• isicanucanu

Eminye imiphumela emibi ingaba mibi. Uma uhlangabezana nenye yalezi zimpawu noma lezo ezibalwe esigabeni ESIBALULEKILE SESEXWAYISO, shayela udokotela wakho ngokushesha:

• ukuphefumula okwenzeka ngesikhathi uphumule, ngemuva kokuvivinya umzimba okuncane, noma ngemuva kwanoma imuphi umsebenzi owenziwe ngokomzimba
• ubuhlungu besifuba
• okusheshayo, okuhamba kancane, okushaya ngamandla, noma ukushaya kwenhliziyo okungajwayelekile
• ukuqubuka
• ukuvuvukala kobuso, umphimbo, ulimi, izindebe namehlo

I-Ticagrelor ingadala eminye imiphumela emibi. Shayela udokotela wakho uma unezinkinga ezingavamile ngenkathi uthatha lo muthi.

Uma uthola imiphumela emibi kakhulu, wena noma udokotela wakho ungathumela umbiko kuhlelo lwe-Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting online (http://www.fda.gov/Safety/MedWatch) noma ngocingo ( 1-800-332-1088).

Gcina le mithi esitsheni efike ngayo, ivalwe ngokuqinile, futhi lapho izingane zingafinyeleleki khona. Gcina ekamelweni lokushisa futhi kude nokushisa okweqile nomswakama (hhayi endlini yangasese).

Kubalulekile ukugcina yonke imishanguzo ingabonakali futhi ifinyeleleke ezinganeni njengoba iziqukathi eziningi (njengezingqondo zamaphilisi zamasonto onke kanye nalawo amaconsi wamehlo, okhilimu, amabala, kanye nama-inhalers) azimeleki ezinganeni futhi izingane ezincane zingazivula kalula. Ukuvikela izingane ezisencane ekufakeni ubuthi, hlala uvala amakepisi okuphepha bese ubeka umuthi endaweni ephephile - eyodwa ephezulu futhi engekho futhi engabonakali kubo futhi efinyelela kuyo. http://www.upandaway.org

Imithi engadingeki kufanele ilahlwe ngezindlela ezikhethekile zokuqinisekisa ukuthi izilwane ezifuywayo, izingane nabanye abantu abakwazi ukuzidla. Kodwa-ke, akufanele ukhiphe le mithi ethoyilethi. Esikhundleni salokho, indlela engcono kakhulu yokulahla imithi yakho ngohlelo lokubuyisa umuthi. Khuluma nosokhemisi wakho noma uthinte umnyango wangakini wokulahla udoti / wokusebenzisa kabusha ukuze ufunde ngezinhlelo zokubuyisa emphakathini wakho. Bheka iwebhusayithi yakwa-FDA's Safe Disposal of Medicines (http://goo.gl/c4Rm4p) ukuthola eminye imininingwane uma ungakwazi ukufinyelela kuhlelo lokubuyisa.

Uma kwenzeka ukweqisa ngokweqile, shayela ucingo losizo lokulawula ubuthi ku-1-800-222-1222. Imininingwane iyatholakala online ku-https: //www.poisonhelp.org/help. Uma isisulu siwile, saba nokuquleka, sinenkinga yokuphefumula, noma singakwazi ukuvuswa, shayela ngokushesha abezimo eziphuthumayo ku-911.

Izimpawu zokudlula ngokweqile zingafaka okulandelayo:

• ukopha
• isicanucanu
• ukuhlanza
• isifo sohudo
• ukushaya kwenhliziyo okungajwayelekile

Gcina wonke ama-aphoyintimenti nodokotela wakho kanye nelabhorethri. Udokotela wakho angalawula izivivinyo ezithile zebhu ukuze ahlole impendulo yomzimba wakho ku-ticagrelor.

Ngaphambi kokwenza noma yiluphi uvivinyo lwelabhoratri, tshela udokotela wakho kanye nabasebenzi be-laboratory ukuthi uthatha i-ticagrelor.

Ungavumeli omunye umuntu ukuthi athathe imithi yakho. Buza usokhemisi wakho noma imiphi imibuzo onayo mayelana nokugcwalisa umuthi wakho.

Kubalulekile ukuthi ugcine uhlu olubhaliwe lwayo yonke imishanguzo oyisebenzisayo kadokotela kanye nokungabhaliswanga (ngaphezulu kokuthenga), kanye nanoma yimiphi imikhiqizo efana namavithamini, amaminerali, noma ezinye izithako zokudla. Kufanele uze nalolu hlu njalo uma uvakashela udokotela noma uma ungeniswa esibhedlela. Kubaluleke kakhulu futhi nemininingwane ebalulekile ukuthi uphathe uma kwenzeka kunezimo eziphuthumayo.

• Brilinta^®